Skip to main content

Ikarian Capital, LLC

Position in ALEC — Alector, Inc.

CIK 1778253 DALLAS, TX

Position in ALEC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,477,602
+$1,228,737 QoQ
Shares Held
2,082,606
0.0% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Derivatives in ALEC

reported options exposure · as of Jun 30, 2021
CallValue
$464,509
CallShares
22,300
PutValue
$464,509
PutShares
22,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $653,059,812 across 106 Biotechnology names. ALEC ranks #42 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALEC

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,477,602 2,082,606
2025-12-31 $3,248,865 2,082,606
2025-09-30 $2,249,600 760,000
2025-06-30 $1,260,000 900,000
2025-03-31 $1,168,500 950,000
2024-12-31 $1,795,500 950,000
2021-06-30 $14,054,480 674,723
2021-06-30 $464,509 22,300
2021-06-30 $464,509 22,300
2021-03-31 $5,186,050 257,500
2020-12-31 $869,975 57,500
2020-09-30 $3,381 321